News | RIVM

Patient with cutaneous diphtheria in reception centre

This week, a refugee from Syria was found to be infected with the diphtheria bacterium. The patient has been treated with antibiotics. The patient’s contacts have been tested and vaccinated.

Side effect reports National Immunisation Programme 2021

Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have

Participation in National Immunisation Programme shows slight decrease

Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.

Impact of coronavirus outbreak on participation in National Immunisation Programme limited

Participation in the vaccinations against mumps, measles and rubella (MMR) and diphtheria, pertussis (whooping cough), tetanus and polio) (DTaP-IPV) has decreased slightly among infants (-1%).

Vader en moeder spelen met jonge kinderen met speelgoed

RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine

Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.

Jongen en meisjes poseren op een kruk voor campagneposter HPV vaccin

The National Immunisation Programme: the number of disease notifications decreased substantially in 2020

In 2020, fewer people fell ill from a disease against which vaccination is included in the National Immunisation Programme than in 2019. This is most likely due to coronavirus measures, such as social distancing, handwashing, and travel restrictions.

Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

Vaccination rate increased, HPV even significantly

For the first time in five years, the number of children receiving vaccinations from the National Immunisation Programme has increased slightly.

Corona crisis has limited impact on infant participation in National Immunisation Programme

Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.

More children vaccinated against mumps, measles, rubella and HPV

The percentage of newborns participating in the immunisation programme targeting mumps, measles and rubella rose slightly over the past year.